These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22665955)

  • 21. Prescription drug abuse in Canada and the diversion of prescription drugs into the illicit drug market.
    Haydon E; Rehm J; Fischer B; Monga N; Adlaf E
    Can J Public Health; 2005; 96(6):459-61. PubMed ID: 16350874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Illicit and prescription drug misuse as reported to the Maine Diversion Alert Program.
    Piper BJ; Suarez MJ; Piserchio JP; Shah DT; Simoyan OM; McCall KL; Desrosiers CE; Nichols SD
    Forensic Sci Int; 2018 Apr; 285():65-71. PubMed ID: 29453006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Collaboration or coercion? Partnering to divert prescription opioid medications.
    Green TC; Bowman SE; Ray M; Zaller N; Heimer R; Case P
    J Urban Health; 2013 Aug; 90(4):758-67. PubMed ID: 23371052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. From dispensed to disposed: evaluating the effectiveness of disposal programs through a comparison with prescription drug monitoring program data.
    Egan KL; Gregory E; Sparks M; Wolfson M
    Am J Drug Alcohol Abuse; 2017 Jan; 43(1):69-77. PubMed ID: 27797283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prescription opioid related misuse, harms, diversion and interventions in Canada: a review.
    Fischer B; Argento E
    Pain Physician; 2012 Jul; 15(3 Suppl):ES191-203. PubMed ID: 22786457
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-medical use and abuse of commonly prescribed medications.
    Riggs P
    Curr Med Res Opin; 2008 Mar; 24(3):869-77. PubMed ID: 18267053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dental opioid prescribing practices and risk mitigation strategy implementation: Identification of potential targets for provider-level intervention.
    McCauley JL; Leite RS; Melvin CL; Fillingim RB; Brady KT
    Subst Abus; 2016; 37(1):9-14. PubMed ID: 26675303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluating the potential impact of a reformulated version of oxycodone upon tampering, non-adherence and diversion of opioids: the National Opioid Medications Abuse Deterrence (NOMAD) study protocol.
    Degenhardt L; Larance B; Bruno R; Lintzeris N; Ali R; Farrell M
    Addiction; 2015 Feb; 110(2):226-37. PubMed ID: 25358480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Examining social supply among nonmedical prescription stimulant users in the San Francisco Bay Area.
    Murphy F; Murphy S; Sales P; Lau N
    Int J Drug Policy; 2018 Apr; 54():68-76. PubMed ID: 29414488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Demystifying buprenorphine misuse: Has fear of diversion gotten in the way of addressing the opioid crisis?
    Doernberg M; Krawczyk N; Agus D; Fingerhood M
    Subst Abus; 2019; 40(2):148-153. PubMed ID: 31008694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. National drug control policy and prescription drug abuse: facts and fallacies.
    Manchikanti L
    Pain Physician; 2007 May; 10(3):399-424. PubMed ID: 17525776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abuse-Deterrent Formulations and the Prescription Opioid Abuse Epidemic in the United States: Lessons Learned From OxyContin.
    Cicero TJ; Ellis MS
    JAMA Psychiatry; 2015 May; 72(5):424-30. PubMed ID: 25760692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Diversion of Prescription Opioid Analgesics.
    Inciardi JA; Surratt HL; Lugo Y; Cicero TJ
    Law Enforc Exec Forum; 2007 Nov; 7(7):127-141. PubMed ID: 25267926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance.
    Manchikanti L; Abdi S; Atluri S; Balog CC; Benyamin RM; Boswell MV; Brown KR; Bruel BM; Bryce DA; Burks PA; Burton AW; Calodney AK; Caraway DL; Cash KA; Christo PJ; Damron KS; Datta S; Deer TR; Diwan S; Eriator I; Falco FJ; Fellows B; Geffert S; Gharibo CG; Glaser SE; Grider JS; Hameed H; Hameed M; Hansen H; Harned ME; Hayek SM; Helm S; Hirsch JA; Janata JW; Kaye AD; Kaye AM; Kloth DS; Koyyalagunta D; Lee M; Malla Y; Manchikanti KN; McManus CD; Pampati V; Parr AT; Pasupuleti R; Patel VB; Sehgal N; Silverman SM; Singh V; Smith HS; Snook LT; Solanki DR; Tracy DH; Vallejo R; Wargo BW;
    Pain Physician; 2012 Jul; 15(3 Suppl):S67-116. PubMed ID: 22786449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Provider Prescription Drug Monitoring Program Utilization and Self-Auditing-A Pilot Study.
    Brown WC; Whitted K
    J Dr Nurs Pract; 2020 Jul; 13(2):142-147. PubMed ID: 32817503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diversion of methadone and buprenorphine by patients in opioid substitution treatment in Sweden: prevalence estimates and risk factors.
    Johnson B; Richert T
    Int J Drug Policy; 2015 Feb; 26(2):183-90. PubMed ID: 25465344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associations between statewide prescription drug monitoring program (PDMP) requirement and physician patterns of prescribing opioid analgesics for patients with non-cancer chronic pain.
    Lin HC; Wang Z; Boyd C; Simoni-Wastila L; Buu A
    Addict Behav; 2018 Jan; 76():348-354. PubMed ID: 28898808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prescription Monitoring Program Trends Among Individuals Arrested in Maine for Trafficking Prescription Drugs in 2014.
    McCall K; Nichols SD; Holt C; Ochs L; Cattabriga G; Tu C
    Pharmacotherapy; 2016 Jun; 36(6):585-9. PubMed ID: 27087386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The diversion of stimulant medications among a convenience sample of college students with current prescriptions.
    Gallucci AR; Martin RJ; Usdan SL
    Psychol Addict Behav; 2015 Mar; 29(1):154-61. PubMed ID: 25134041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The US Opioid Crisis: Current Federal and State Legal Issues.
    Soelberg CD; Brown RE; Du Vivier D; Meyer JE; Ramachandran BK
    Anesth Analg; 2017 Nov; 125(5):1675-1681. PubMed ID: 29049113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.